Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ying-Jun Chang

Showing results (211-220 of 236) with videos related to

Pageof 24
Sort By:
Cancer Letters|July 5, 2024
Measurable residual disease testing by next generation sequencing is more accurate compared with multiparameter flow cytometry in adults with B-cell acute lymphoblastic leukemiaNan Yan, Zi-Long Wang, Xiao-Juan Wang, et al.
Leukemia|April 7, 2021
Unmanipulated haploidentical hematopoietic stem cell transplantation is an excellent option for children and young adult relapsed/refractory Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia after CAR-T-cell therapyGuan-Hua Hu, Xiang-Yu Zhao, Ying-Xi Zuo, et al.
Frontiers in Oncology|September 6, 2021
Risk Stratification of Cytogenetically Normal Acute Myeloid Leukemia With Biallelic <i>CEBPA</i> Mutations Based on a Multi-Gene Panel and Nomogram ModelLi-Xin Wu, Hao Jiang, Ying-Jun Chang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 4, 2019
Incidence, Risk Factors, and Outcome of Immune-Mediated Neuropathies (IMNs) following Haploidentical Hematopoietic Stem Cell TransplantationXi-Ying Ren, Xiao Liu, Qiu-Sha Huang, et al.
Transplantation and Cellular Therapy|October 22, 2022
Machine learning algorithm as a prognostic tool for venous thromboembolism in allogeneic transplant patientsRui-Xin Deng, Xiao-Lu Zhu, Ao-Bei Zhang, et al.
Frontiers in Immunology|January 24, 2022
Chimeric Antigens Receptor T Cell Therapy Improve the Prognosis of Pediatric Acute Lymphoblastic Leukemia With Persistent/Recurrent Minimal Residual Disease in First Complete RemissionGuan-Hua Hu, Yi-Fei Cheng, Ying-Xi Zuo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 28, 2018
Myeloablative Haploidentical Transplantation Is Superior to Chemotherapy for Patients with Intermediate-risk Acute Myelogenous Leukemia in First Complete RemissionMeng Lv, Yu Wang, Ying-Jun Chang, et al.
American Journal of Hematology|September 29, 2023
A predictive model of herpes zoster after allogeneic hematopoietic stem cell transplantation: VZV reactivation following antiviral prophylaxis discontinuationCheng-Jie Feng, Peng Zhao, Hai-Xia Fu, et al.
Annals of Hematology|May 5, 2019
Incidence, risk factors and outcomes of sinusoidal obstruction syndrome after haploidentical allogeneic stem cell transplantationXuan Cai, Jin Wu, Ruo-Yun Gui, et al.
Cancer Letters|August 31, 2024
Clinical characteristics and risk stratification for late-onset herpes zoster following allogeneic hematopoietic stem cell transplantationCheng-Jie Feng, Peng Zhao, Hai-Xia Fu, et al.
Pageof 24

Showing results (211-220 of 236) with videos related to

Sort By:
Pageof 24
Cancer Letters|July 5, 2024
Measurable residual disease testing by next generation sequencing is more accurate compared with multiparameter flow cytometry in adults with B-cell acute lymphoblastic leukemiaNan Yan, Zi-Long Wang, Xiao-Juan Wang, et al.
Leukemia|April 7, 2021
Unmanipulated haploidentical hematopoietic stem cell transplantation is an excellent option for children and young adult relapsed/refractory Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia after CAR-T-cell therapyGuan-Hua Hu, Xiang-Yu Zhao, Ying-Xi Zuo, et al.
Frontiers in Oncology|September 6, 2021
Risk Stratification of Cytogenetically Normal Acute Myeloid Leukemia With Biallelic <i>CEBPA</i> Mutations Based on a Multi-Gene Panel and Nomogram ModelLi-Xin Wu, Hao Jiang, Ying-Jun Chang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 4, 2019
Incidence, Risk Factors, and Outcome of Immune-Mediated Neuropathies (IMNs) following Haploidentical Hematopoietic Stem Cell TransplantationXi-Ying Ren, Xiao Liu, Qiu-Sha Huang, et al.
Transplantation and Cellular Therapy|October 22, 2022
Machine learning algorithm as a prognostic tool for venous thromboembolism in allogeneic transplant patientsRui-Xin Deng, Xiao-Lu Zhu, Ao-Bei Zhang, et al.
Frontiers in Immunology|January 24, 2022
Chimeric Antigens Receptor T Cell Therapy Improve the Prognosis of Pediatric Acute Lymphoblastic Leukemia With Persistent/Recurrent Minimal Residual Disease in First Complete RemissionGuan-Hua Hu, Yi-Fei Cheng, Ying-Xi Zuo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 28, 2018
Myeloablative Haploidentical Transplantation Is Superior to Chemotherapy for Patients with Intermediate-risk Acute Myelogenous Leukemia in First Complete RemissionMeng Lv, Yu Wang, Ying-Jun Chang, et al.
American Journal of Hematology|September 29, 2023
A predictive model of herpes zoster after allogeneic hematopoietic stem cell transplantation: VZV reactivation following antiviral prophylaxis discontinuationCheng-Jie Feng, Peng Zhao, Hai-Xia Fu, et al.
Annals of Hematology|May 5, 2019
Incidence, risk factors and outcomes of sinusoidal obstruction syndrome after haploidentical allogeneic stem cell transplantationXuan Cai, Jin Wu, Ruo-Yun Gui, et al.
Cancer Letters|August 31, 2024
Clinical characteristics and risk stratification for late-onset herpes zoster following allogeneic hematopoietic stem cell transplantationCheng-Jie Feng, Peng Zhao, Hai-Xia Fu, et al.
Pageof 24